Designing and testing new intervention therapies for lung cancer and mesothelioma

Designing and testing new intervention therapies for lung cancer and mesothelioma - New intervention therapies for lung cancer and mesothelioma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34325

Enrollment

Registered

2010-08-18

Start date

2010-08-30

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lungcancer mesothelioma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Histologically proven lungcancer (SCLC or NSCLC) or mesothelioma

Exclusion criteria

Exclusion criteria: Other malignant tumor than lungcancer or mesothelioma

Design outcomes

Primary

Measure	Time frame
Validate the findings of mouse-models in human tumor samples using pre-and post-treatment surgical specimen and by studying the response/resistance of primary explants of human tumors.	—

Countries

Netherlands

Outcome results